期刊文献+

Parkin基因在鼻咽癌中转录表达及临床意义 被引量:1

mRNA expression of Parkin gene in human nasopharyngeal carcinoma and its clinical significance
下载PDF
导出
摘要 目的研究Parkin基因在鼻咽癌中转录表达及临床意义。方法运用半定量逆转录PCR的方法检测54例鼻咽癌组织和16例正常鼻咽上皮组织Parkin基因转录表达水平,分析Parkin基因转录表达与鼻咽癌患者临床病理特征关系。结果 54例鼻咽癌组织Parkin基因相对转录表达水平为0.3430±0.4947,16例正常鼻咽上皮组织Parkin基因相对转录表达水平为1.0052±0.4911,鼻咽癌组织Parkin转录表达明显下调,Parkin基因转录表达与患者年龄、性别、T分级、TNM分期、病理类型无明显关系,而与淋巴结转移有关。结论 Parkin在鼻咽癌的发生发展中起抑癌基因作用,Parkin基因转录表达可作为判断鼻咽癌临床预后预测指标。 OBJECTIVE To study the mRNA expression of Parkin gene in human nasopharyngeal carcinoma (NPC) and its clinical significance. METHODS The semi-quantitative reverse transcription PCR (RTPCR) was used to detect the mRNA expression level of Parkin gene in 54 human NPC tissues and 16 normal nasopharyngeal epithelial tissues. The relationship between mRNA expression of the gene and clinical data was analyzed. RESULTS The mRNA expression level was significantly decreased in 54 human NPC tissues (0.3430± 0.4947) than that in 16 normal nasopharyngeal epithelia tissues (1.0052±0.4911). The decreased mRNA expression of Parkin was not related with age, gender, T stage, TNM classification and histopathologic subtype, but was related with N stage. CONCLUSION Parkin gene mRNA expression may play an important role in the genesis and development of human NPC. The mRNA expression of Parkin may serve as an important indicator in predicting the prognosis of human NPC.
出处 《中国耳鼻咽喉头颈外科》 CSCD 2014年第5期233-235,共3页 Chinese Archives of Otolaryngology-Head and Neck Surgery
基金 浙江省医药卫生科技一般项目(2011KYA127) 浙江省医药卫生骨干平台项目(2012RCB038)联合资助
关键词 鼻咽肿瘤 聚合酶链反应 PARKIN基因 预后 Nasopharyngeal Neoplasms Polymerase Chain Reaction Parkin Genes Prognosis
  • 相关文献

参考文献7

  • 1Tay SP, Yeo CW, Chai C, et al. Parkin enhances the expression of cyclin-dependent kinase 6 and negatively regulates the proliferation of breast cancer ceils. J Biol Chem, 2010, 285: 29231-29238.
  • 2Mehdi S J, Ali A, Rizvi MM. Parkin gene alterations in ovarian carcinoma from northern Indian population. Pathol Oncol Res, 2011, 17: 579-586.
  • 3Picchio MC, Martin ES, Cesari R, et al. Alterations of the tumor suppressor gene parkin in non-small cell lung cancer. Clin Cancer Res, 2004, 10: 2720-2724.
  • 4Fujiwara M, Marusawa H, Wang HQ, et al. Parkin as a tumor suppressor gene for hepatocellular carcinoma. Oneogene, 2008, 27: 6002-6011.
  • 5Agirre X, Roman-Gomez J, Vazquez I, et al. Abnormal metbylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia. Int J Cancer, 2006, 118: 1945-1953.
  • 6Ikeuchi K, Marusawa H, Fujiwara M, et al. Attenuation of proteolysis-mediated cyclin E regulation by alternatively spliced Parkin in human colorectal cancers. Int J Cancer, 2009, 125: 2029-2035.
  • 7陈钢,王怡,易继林,李兴睿,刘谨文,沈文状,刘峰.Parkin基因在肝细胞癌中的表达与临床意义[J].中华肝胆外科杂志,2006,12(9):619-621. 被引量:4

二级参考文献5

  • 1Hui AM, Makuuchi M. Molecular basis of multistep hepatocarcinogenesis: genetic and epigenetic events. Scand J Gastroenterol,1999, 34: 737-742.
  • 2Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature,1998, 392:605-608.
  • 3Cesari R, Martin ES, Calin GA, et al. Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27. Proc Natl Acad Sci USA, 2003, 100: 5956-5961.
  • 4Wang F, Stacy D, Jin-Ping Lai, et al. Parkin gene alterations in hepatocellular carcinoma. Genes Chromosomes Cancer, 2004,40: 85-96.
  • 5Picchio MC, Martin ES, Cesari R, et al. Alterations of the tumor suppressor gene parkin in non-small cell lung cancer. Clin Cancer Res, 2004, 10: 2720-2724.

共引文献3

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部